Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 14 years ofrich experience in this field. He is an alumni of Maulana Azad Medical College Delhi from where he did his MBBS, followed by MD Medicine. He has done his DM Medical Oncology from the prestigious AIIMS New Delhi. He has also completed course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise in Immunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care. He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Pappiloma Virus trends in Indian Population etc. He is also the leadfounder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes and workshops in oncology Dr.Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and Haematology Oncology, Previously he was associated with prestigious organisation like Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College.